Technology for the Taking at Research Hub in Scotland

Publication
Article
Oncology Live®December 2010
Volume 11
Issue 12

The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge

The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge as a way to speed up the move of intellectual property (IP) from the academic enclave to the marketplace.

The Scottish institution said it is the first university in the United Kingdom to take such a step, which the school described in a press release as part of its libertarian orientation. The technologies will be offered through a Website, Easy Access IP (www.glasgow. ac.uk/technology).

The cancer-related offerings include a telomerase targeted adenoviral suicide-gene therapy vector that has been tested on ovarian cancer cells and a sensor technology called Lab-in- a-Pill that may be used to detect colorectal cancer.

Related Videos
Heinz-Josef Lenz, MD, FACP
Scott Kopetz, MD, PhD, FACP
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
Michael Leung, PharmD, an expert on colorectal cancer
A panel of 4 experts on colorectal cancer
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Erin K. Crane, MD, MPH
Núria Agustí Garcia, MD
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer